Browsed by
Category: Press Releases

Genesys Raises $580 Million in Funding at $21 Billion Valuation

Genesys Raises $580 Million in Funding at $21 Billion Valuation

Round is led with investment by Salesforce Ventures with participation from ServiceNow Ventures and Zoom Video Communications, to strengthen Genesys leadership in the Experience as a Service(SM) market

SAN FRANCISCODec. 6, 2021 /PRNewswire/ — Genesys®, a global cloud leader in customer experience orchestration, today announced a $580 million round of funding, which is intended to accelerate the company’s leadership in the Experience as a Service market globally. The oversubscribed round was led by Salesforce Ventures with participation from other investors ServiceNow Ventures; Zoom Video Communications; funds and accounts managed by BlackRock, D1 Capital Partners and another large US-based West Coast mutual fund manager. This offering values Genesys at a valuation of $21 billion...  Read more

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., December 3, 2021 — United Therapeutics (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today announced that the company has been named on Newsweek’s list of America’s Most Responsible Companies 2022. This award is presented by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list was announced on December 2, 2021, available on Newsweek’s website, recognizes the top 500 most responsible companies in the United States, spanning 14 industries. ...  Read more

Xometry Acquires Thomas For $300M

Xometry Acquires Thomas For $300M

ROCKVILLE, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) — Xometry (NASDAQ: XMTR), the global marketplace for on-demand manufacturing, today announced the acquisition of Thomas (Thomasnet.com), a leader in product sourcing, supplier selection and digital marketing solutions. The cash and stock transaction, valued at $300 million, is expected to close this week. Xometry’s rapidly growing digital marketplace provides real-time access to global manufacturing capacity and demand, helping accelerate the digitization of the manufacturing industry. ...  Read more

Federal Realty Plans 10-Story Life Science Facility at Pike & Rose to Fuel Extension of Montgomery County’s Life Science and Biotech Corridor to North Bethesda

Federal Realty Plans 10-Story Life Science Facility at Pike & Rose to Fuel Extension of Montgomery County’s Life Science and Biotech Corridor to North Bethesda

North Bethesda, Md. (December 1, 2021) – Federal Realty Investment Trust (NYSE:FRT) is setting the new standard for life science facilities with plans for an iconic, amenity rich 935 Prose, located in the heart of North Bethesda’s Pike & Rose. The project will be designed by internationally acclaimed architect, Gensler, and the 10-story state-of-the-art building will extend the biotech corridor beyond
Shady Grove to Pike & Rose, the premier transit-oriented destination for shopping, dining, living, and working in Montgomery County. ...  Read more

Creative Bio-Peptides Awarded $5.78 from NIH to Develop Breakthrough Treatments for Neuroinflammatory/Neurodegenerative Indications

Creative Bio-Peptides Awarded $5.78 from NIH to Develop Breakthrough Treatments for Neuroinflammatory/Neurodegenerative Indications

Creative Bio-Peptides, Inc., an emerging drug development company focused on the development of leading-edge multi-chemokine antagonist therapeutic peptides for neuroinflammatory/neurodegenerative conditions, has been awarded $5.8M in non-dilutive funding from three NIH agencies. ...  Read more

PSOMAGEN, INC. IS PARTNERING WITH OLINK PROTEOMICS, ENABLING UNPRECEDENTED MULTI-OMICS CLINICAL STUDIES

PSOMAGEN, INC. IS PARTNERING WITH OLINK PROTEOMICS, ENABLING UNPRECEDENTED MULTI-OMICS CLINICAL STUDIES

ROCKVILLE, Md. — November 11, 2021 — Psomagen, Inc., a North American sequencing-based contract laboratory service and data analysis provider with both CLIA-certified and CAP-accredited facilities, has partnered with Olink Proteomics, which offers an innovative DNA-coupled immunoassay that identifies and quantifies protein biomarkers in clinical samples. The partnership enables end-to-end multi-omics clinical studies, a step that will enable a whole new generation of precision therapies derived from a more robust knowledge of human biology. ...  Read more